10-KPeriod: FY2024

UNITEDHEALTH GROUP INC Annual Report, Year Ended Dec 31, 2024

Filed February 27, 2025For Securities:UNH

Summary

UnitedHealth Group Inc. (UNH) presented a solid financial performance for the year ended December 31, 2024, marked by an 8% increase in total revenues to $400.3 billion. This growth was primarily driven by strong performance in its Optum segment, particularly Optum Rx and Optum Health, which saw revenue increases of 15% and 11% respectively, alongside a 6% rise in UnitedHealthcare's revenue. Despite a reported net loss of $7.98 billion on a diluted EPS basis (or $15.51 per share) due to a significant loss on the sale of its Brazil operations and other South American businesses ($8.3 billion), the company demonstrated operational resilience. Key operational highlights include serving a larger member base through UnitedHealthcare's domestic offerings, with a 5% increase in total individuals served. The company also managed the significant impact of the Change Healthcare cyberattack, incurring $2.2 billion in direct response costs and an estimated $867 million in business disruption impacts for Optum Insight, while providing over $9 billion in interest-free loans to care providers. Management remains focused on navigating medical cost trends, government funding pressures in Medicare Advantage, and ongoing investments in value-based care models and technology, positioning the company for continued strategic growth.

Financial Statements
Beta
Revenue$400.28B
Cost of Revenue$46.69B
Gross Profit$353.58B
SG&A Expenses$53.01B
Operating Expenses$367.99B
Operating Income$32.29B
Interest Expense$3.91B
Net Income$14.40B
EPS (Basic)$15.64
EPS (Diluted)$15.51
Shares Outstanding (Basic)921.00M
Shares Outstanding (Diluted)929.00M

Key Highlights

  • 1Total revenues increased by 8% to $400.3 billion, driven by strong growth across Optum Rx (+15%) and Optum Health (+11%), and UnitedHealthcare (+6%).
  • 2Despite a reported net loss of $7.98 billion (EPS of $15.51), primarily due to the sale of South American operations, operational earnings remained stable at $32.3 billion.
  • 3UnitedHealthcare saw an increase of 2.1 million individuals served domestically, reflecting growth in commercial offerings, though partially offset by Medicaid redeterminations.
  • 4The company incurred $2.2 billion in direct response costs and $867 million in business disruption impacts from the Change Healthcare cyberattack, while providing $9 billion in interest-free loans to care providers.
  • 5Optum Health served approximately 100 million people, with revenue growth driven by value-based care arrangements.
  • 6The company continues to invest in value-based care models and advanced analytics and technology, crucial for its long-term strategy.
  • 7Dividend per share increased to an annual rate of $8.40, and the company repurchased $9 billion in common stock during the year.

Frequently Asked Questions

UnitedHealth Group's total revenues grew by 8% to $400.3 billion in 2024. This growth was primarily driven by strong performance in its Optum segment, with Optum Rx revenue increasing by 15% and Optum Health revenue rising by 11%. UnitedHealthcare also contributed with a 6% revenue increase.

The Change Healthcare cyberattack resulted in $2.2 billion in direct response costs for the year ended December 31, 2024, which included providing over $9 billion in interest-free loans to care providers. Optum Insight also experienced an estimated $867 million in business disruption impacts due to lost revenue. The company expects to continue incurring some response costs and business disruption impacts in 2025.

The company notes ongoing pressure on Medicare Advantage funding due to rate notices from CMS that are below forward medical cost trends. They also observed increased care patterns and higher hospital coding intensity. To mitigate these pressures, UnitedHealth Group may adjust care provider networks, member benefits, and premiums, and selectively choose markets for Medicare Advantage offerings.

UnitedHealth Group generated $24.2 billion in cash flows from operations. The company increased its quarterly cash dividend to an annual rate of $8.40 per share and repurchased approximately $9 billion of its common stock during 2024. The company also has a significant portfolio of cash, cash equivalents, and investments totaling $77.1 billion as of year-end 2024, providing substantial financial flexibility.